ERLOTINIB 150 mg/1

Erlotinib 150 mg tablets are a targeted therapy used in cancer treatment. This oral medication is designed to inhibit specific proteins that contribute to cancer cell growth.

Erlotinib is primarily used in the treatment of certain types of cancer, such as non-small cell lung cancer and pancreatic cancer. It works by targeting and inhibiting the epidermal growth factor receptor (EGFR), which can help slow down the growth and spread of cancer cells. Patients often wonder, 'What is Erlotinib used for?' and the answer lies in its role as a targeted therapy for these specific cancer types.

Common effects of Erlotinib may include skin rash, diarrhea, and fatigue. Some patients may also experience loss of appetite or nausea. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Erlotinib should be handled with care and stored as directed. It is important to follow the advice of a healthcare provider regarding the use of this medication. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Erlotinib may interact with certain medications, including those that are metabolized by the liver enzyme CYP3A4. It is also advisable to avoid grapefruit and grapefruit juice, as they can affect the metabolism of Erlotinib. Always consult a healthcare provider before starting or stopping any medication.